Dysprosody differentiate between Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy

被引：4
|
作者：
Hlavnicka, Jan [1 ]
Tykalova, Tereza [1 ]
Cmejla, Roman [1 ]
Klempir, Jiri [2 ,3 ]
Ruzicka, Evzen [2 ,3 ]
Rusz, Jan [1 ,2 ,3 ]
机构：
[1] Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, Tech 2, Prague 16627 6, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Dept Neurol, Katerinska 30, Prague 12000 2, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Katerinska 30, Prague 12000 2, Czech Republic
来源：
18TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2017), VOLS 1-6: SITUATED INTERACTION | 2017年
关键词：
automated acoustic analysis; speech disorder; dysprosody; atypical parkinsonian syndromes; Parkinson's disease; progressive supranuclear palsy; multiple system atrophy; SPEECH CHARACTERISTICS; PERCEPTUAL ANALYSIS; LARGE-SAMPLE; DYSARTHRIA; DIAGNOSIS; ARTICULATION; IMPAIRMENT; DISORDERS; CRITERIA;
D O I：
10.21437/Interspeech.2017-762
中图分类号：
TP18 [人工智能理论];
学科分类号：
081104 ; 0812 ; 0835 ; 1405 ;
摘要：
Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) are distinctive neurodegenerative disorders, which manifest similar motor features. Their differentiation is crucial but difficult. Dysfunctional speech, especially dysprosody, is a common symptom accompanying PD, PSP, and MSA from early stages. We hypothesized that automated analysis of monologue could provide speech patterns distinguishing PD, PSP, and MSA. We analyzed speech recordings of 16 patients with PSP, 20 patients with MSA, and 23 patients with PD. Our findings revealed that deviant pause production differentiated between PSP, MSA, and PD. In addition, PSP showed greater deficits in speech respiration when compared to MSA and PD. Automated analysis of connected speech is easy to administer and could provide valuable information about underlying pathology for differentiation between PSP, MSA, and PD.
引用
收藏
页码：1844 / 1848
页数：5
相关论文
共 50 条
  • [41] Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy
    Guevara, C. A.
    Blain, C. R.
    Stahl, D.
    Lythgoe, D. J.
    Leigh, P. N.
    Barker, G. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (09) : 1193 - 1202
  • [42] Serum uric acid levels in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
    Sakuta, H.
    Suzuki, K.
    Numao, A.
    Miyamoto, M.
    Miyamoto, T.
    Watanabe, Y.
    Fujita, H.
    Watanabe, Y.
    Hashimoto, K.
    Hirata, K.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S126 - S126
  • [43] Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
    Mitchell, Trina
    Wilkes, Bradley J.
    Archer, Derek B.
    Chu, Winston T.
    Coombes, Stephen A.
    Lai, Song
    McFarland, Nikolaus R.
    Okun, Michael S.
    Black, Mieniecia L.
    Herschel, Ellen
    Simuni, Tanya
    Comella, Cynthia
    Afshari, Mitra
    Xie, Tao
    Li, Hong
    Parrish, Todd B.
    Kurani, Ajay S.
    Corcos, Daniel M.
    Vaillancourt, David E.
    [J]. NEUROIMAGE-CLINICAL, 2022, 34
  • [44] Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease
    Lee, Young-Eun C.
    Williams, David R.
    Anderson, Jacqueline F. I.
    [J]. JOURNAL OF NEUROPSYCHOLOGY, 2016, 10 (01) : 1 - 14
  • [45] Brainstem surface measurment by MRI is useful to differentiate Idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP)
    Rolland, Y
    Verin, M
    Payan, C
    Bensimon, G
    [J]. MOVEMENT DISORDERS, 2005, 20 : S104 - S105
  • [46] Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
    Talai, Aron S.
    Sedlacik, Jan
    Boelmans, Kai
    Forkert, Nils D.
    [J]. NEUROIMAGE-CLINICAL, 2018, 20 : 1037 - 1043
  • [47] Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy
    Sakuramoto, Hirotaka
    Fujita, Hiroaki
    Suzuki, Keisuke
    Matsubara, Takeo
    Watanabe, Yuji
    Hamaguchi, Mai
    Hirata, Koichi
    [J]. CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 2 : 20 - 24
  • [48] Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy
    Rau, Alexander
    Jost, Wolfgang H.
    von der Warth, Rieka
    Urbach, Horst
    [J]. MOVEMENT DISORDERS, 2021, 36 (09) : 2207 - 2208
  • [49] Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease
    Fiorenzato, Eleonora
    Antonini, Angelo
    Camparini, Valeria
    Weis, Luca
    Semenza, Carlo
    Biundo, Roberta
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (11) : 1437 - 1445
  • [50] Brainstem atrophy quantification by magnetic resonance imaging (MRI) is powerful to differentiate idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP)
    Rolland, Y
    Bruneau, B
    Verin, M
    Payan, C
    Bensimon, G
    [J]. MOVEMENT DISORDERS, 2004, 19 : S371 - S371
12345